DOXORUBICIN Accord sol inj 200 mg/100ml flac
7680687460057
CH-68746
L01DB01
07.16.1.
Reimbursement limitations:
GRANDFRERE11
La quantité totale de l’emballage ne peut pas être remise directement à un assuré.
Seule …
1 / 3
google
Details
- Product number
- 6874605
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- doxorubicini hydrochloridum 200 mg, natrii chloridum corresp. natrium 354 mg, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 100 ml.
Articles (1)
Doxorubicin Accord 200 mg/100 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
354.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 257.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2025
Compulsory until:
31/03/2024
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68746
- Drug name
- Doxorubicin Accord, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 14/07/2022
- Authorization expiration date
- 13/07/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DOXORUBICIN Accord sol inj 200 mg/100ml flac
- Description (DE)
- DOXORUBICIN Accord Inj Lös 200 mg/100ml Durchstf
- Market launch
- 14/07/2022
- Narcotic (BTM)
- No